The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
The Impact of Treatment Noncompliance on Mortality in People With Type 2 Diabetes
Open accessAbstract
OBJECTIVE: To assess the association of compliance with treatment (medication and clinic appointments) and all-cause mortality in people with insulin-treated type 2 diabetes. RESEARCH DESIGN AND METHODS: Data were extracted from U.K. general practice records and included patients (N = 15,984) who had diagnostic codes indicative of type 2 diabetes or who had received a prescription for an oral antidiabetic agent and were treated with insulin. Records in the 30 months before the index date were inspected for clinical codes (recorded at consultation) indicating medication noncompliance or medical appointment nonattendance. Noncompliance was defined as missing more than one scheduled visit or having at least one provider code for not taking medications as prescribed. Relative survival postindex date was compared by determining progression to all-cause mortality using Cox proportional hazards models. RESULTS: Those identified as clinic nonattenders were more likely to be smokers, younger, have higher HbA1c, and have more prior primary care contacts and greater morbidity (P < 0.001). Those identified as medication noncompliers were more likely to be women (P = 0.001), smokers (P = 0.014), and have higher HbA1c, more prior primary care contacts, and greater morbidity (all P < 0.001). After adjustment for confounding factors, medication noncompliance (hazard ratio 1.579 [95% CI 1.167–2.135]), clinic nonattendance of one or two missed appointments (1.163 [1.042–1.299]), and clinic nonattendance of greater than two missed appointments (1.605 [1.356–1.900]) were independent risk factors for all-cause mortality. CONCLUSIONS: Medication noncompliance and clinic nonattendance, assessed during routine care by primary care physicians or their staff, were independently associated with increased all-cause mortality in patients with type 2 diabetes receiving insulin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Care · doi:10.2337/dc08-9025 · Cited by 3,834
Validation and validity of diagnoses in the General Practice Research Database: a systematic review
Herrett, E., Thomas, S. L., Schoonen, W. M., Smeeth, L., & Hall, A. J. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03537.x · Cited by 1,109
Karter, A. J., Ackerson, L. M., Darbinian, J. A., D’Agostino, R. B., Ferrara, A., Liu, J., & Selby, J. V. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00742-2 · Cited by 595
Correlates of Insulin Injection Omission
Peyrot, M., Rubin, R. R., Kruger, D. F., & Travis, L. B. (2010) · Diabetes Care · doi:10.2337/dc09-1348 · Cited by 407
Self-citationAdherence to pharmacologic therapy in patients with type 2 diabetes mellitus
Rubin, R. R. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.04.012 · Cited by 406
Self-citationSecrest, A. M., Becker, D. J., Kelsey, S. F., LaPorte, R. E., & Orchard, T. J. (2010) · Diabetes · doi:10.2337/db10-0862 · Cited by 358
Patient Adherence Improves Glycemic Control
Rhee, M. K., Slocum, W., Ziemer, D. C., Culler, S. D., Cook, C. B., El-Kebbi, I. M., Gallina, D. L., Barnes, C., & Phillips, L. S. (2005) · The Diabetes Educator · doi:10.1177/0145721705274927 · Cited by 339
Bryden, K. S., Neil, A., Mayou, R. A., Peveler, R. C., Fairburn, C. G., & Dunger, D. B. (1999) · Diabetes Care · doi:10.2337/diacare.22.12.1956 · Cited by 323
Roper, N. A., Bilous, R. W., Kelly, W. F., Unwin, N. C., & Connolly, V. M. (2001) · BMJ · doi:10.1136/bmj.322.7299.1389 · Cited by 315
Maguire, A., Blak, B. T., & Thompson, M. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1688 · Cited by 301
Holmes‐Walker, D. J., Llewellyn, A. C., & Farrell, K. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02152.x · Cited by 296
Karter, A. J., Parker, M. M., Moffet, H. H., Ahmed, A. T., Ferrara, A., Liu, J. Y., & Selby, J. V. (2004) · Medical Care · doi:10.1097/01.mlr.0000109023.64650.73 · Cited by 274
Soedamah-Muthu, S. S., Fuller, J. H., Mulnier, H. E., Raleigh, V. S., Lawrenson, R. A., & Colhoun, H. M. (2006) · Diabetologia · doi:10.1007/s00125-005-0120-4 · Cited by 240
Ong, K. L., Cheung, B. M. Y., Wong, L. Y. F., Wat, N. M. S., Tan, K. C. B., & Lam, K. S. L. (2008) · Annals of Epidemiology · doi:10.1016/j.annepidem.2007.10.007 · Cited by 232
Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes
Donnelly, L. A., Morris, A. D., Evans, J. M. M., & for the DARTS/MEMO collaboration (2007) · QJM · doi:10.1093/qjmed/hcm031 · Cited by 230
Relationship between diabetes and mortality: a population study using record linkage.
Morgan, C. L., Currie, C. J., & Peters, J. R. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1103 · Cited by 182
Self-citationDovey‐Pearce, G., Hurrell, R., May, C. R., Walker, C., & Doherty, Y. (2005) · Health & Social Care in the Community · doi:10.1111/j.1365-2524.2005.00577.x · Cited by 180
Secrest, A. M., Becker, D. J., Kelsey, S. F., LaPorte, R. E., & Orchard, T. J. (2010) · Diabetes Care · doi:10.2337/dc10-1170 · Cited by 176
Diabetes Mellitus in the Transition to Adulthood: Adjustment, Self-Care, and Health Status
WYSOCKI, T., HOUGH, B. S., WARD, K. M., & GREEN, L. B. (1992) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-199206000-00007 · Cited by 171
Intensified glucose lowering in type 2 diabetes: time for a reappraisal
Yudkin, J. S., Richter, B., & Gale, E. A. M. (2010) · Diabetologia · doi:10.1007/s00125-010-1864-z · Cited by 156
Yang, Y., Thumula, V., Pace, P. F., Banahan, B. F., Wilkin, N. E., & Lobb, W. B. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.10.002 · Cited by 155
Manuel, D. G., & Schultz, S. E. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.407 · Cited by 153
A survey of validity and utility of electronic patient records in a general practice
Hassey, A., Gerrett, D., & Wilson, A. (2001) · BMJ · doi:10.1136/bmj.322.7299.1401 · Cited by 151 · cited 1×
“has been determined previously (23); however, the practices through which health care professionals assign the codes defining medication noncompliance are yet to be determined.”
BackgroundSikka, R., Waters, J., Moore, W. L., SUTTON, D. R., Herman, W. H., & Aubert, R. E. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.1 · Cited by 139
Information given to patients before appointments and its effect on non-attendance rate
Hardy, K. J., O’Brien, S., & Furlong, N. J. (2001) · BMJ · doi:10.1136/bmj.323.7324.1298 · Cited by 132
Type 1 Diabetes Among Adolescents
Di Battista, A. M., Hart, T. A., Greco, L., & Gloizer, J. (2009) · The Diabetes Educator · doi:10.1177/0145721709333492 · Cited by 123
Clinical inertia in management of T2DM
Zafar, A., Davies, M. J., Azhar, A., & Khunti, K. (2010) · Primary care diabetes · doi:10.1016/j.pcd.2010.07.003 · Cited by 104
Strategies for improving glycemic control: effective use of glucose monitoring
Davidson, J. A. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.07.054 · Cited by 90
Currie, C. J., Gale, E. A. M., & Poole, C. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03040.x · Cited by 69
Self-citationThe influence of psychological factors on the self‐management of insulin‐dependent diabetes mellitus
COATES, V. E., & Boore, J. R. P. (1998) · Journal of Advanced Nursing · doi:10.1046/j.1365-2648.1998.00546.x · Cited by 47
Assessing treatment barriers in young adults with type 1 diabetes
Lancaster, B. M., Pfeffer, B., McElligott, M., Ferguson, A. T., Miller, M. D., Wallace, D. P., & Lane, J. T. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.07.003 · Cited by 44
All-Cause Mortality in the Canterbury (New Zealand) Insulin-Treated Diabetic Registry Population
Brown, L., Scott, R. S., & Moir, C. L. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.56 · Cited by 41
Improvements in life expectancy in adult type 2 diabetes patients in the last six decades
Ioacără, S., Guja, C., Ionescu-Tirgoviste, C., Fica, S. V., Sabău, S. V., Radu, S., Micu, A., & Tiu, C. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.03.022 · Cited by 37
Yurgin, N., Boye, K. S., Dilla, T., Suriñach, N. L., & Badia, X. C. (2008) · PubMed Central · Cited by 27
Rothenbacher, D., Rüter, G., & Brenner, H. (2006) · BMC Family Practice · doi:10.1186/1471-2296-7-42 · Cited by 15
Saunders, S., Wallymhamed, M., & MacFarlane, I. A. (2008) · QJM · doi:10.1093/qjmed/hcn125 · Cited by 14
UKPDS 26: sulphonylurea failure in non-insulin-dependent diabetic patients over six years
UK Prospective Diabetes Study (UKPDS) Group, Matthews, D. R., Cull, C. A., Stratton, I. M., Holman, R. R., & Turner, R. C. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199804)15:4
Cited by
Polonsky, W., & Henry, R. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s106821 · Cited by 784
“7 Similarly, Ho et al 8 reported a significant association between poor medication adherence in T2D and all-cause mortality over time (odds ratio 1.8; P 0.001).”
InfluentialAdherence to Therapies in Patients with Type 2 Diabetes
García-Pérez, L.-E., Álvarez, M., Dilla, T., Gil-Guillén, V., & Orozco-Beltrán, D. (2013) · Diabetes Therapy · doi:10.1007/s13300-013-0034-y · Cited by 726
Gonzalez, J. S., Tanenbaum, M. L., & Commissariat, P. V. (2016) · American Psychologist · doi:10.1037/a0040388 · Cited by 354
“…associated with worse glycemic control (e.g., Feldman et al., 2014; Hood, Peterson, Rohan, & Drotar, 2009; Schectman, Nadkarni, & Voss, 2002) and increased risk for hospitalization, complications, and mortality (e.g., Cho et al., 2011; Currie et al., 2012; Ho et al., 2006; Kuo et al., 2003).”
BackgroundPan, A., Wang, Y., Talaei, M., & Hu, F. B. (2015) · Circulation · doi:10.1161/circulationaha.115.017926 · Cited by 343
Weber, D. R., Haynes, K., Leonard, M. B., Willi, S. M., & Denburg, M. R. (2015) · Diabetes Care · doi:10.2337/dc15-0783 · Cited by 274
Metadata
- Authors
- Currie, C. J., Peyrot, M., Morgan, C. L., Poole, C. D., Jenkins-Jones, S., Rubin, R. R., Burton, C. M., & Evans, M.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-05-11
- Volume
- 35
- Issue
- 6
- Pages
- 1279-1284
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2036387352
- Cited by
- 252
- References
- 40
- FWCI
- 12.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.